Member Info for ontarget

Sorry ignore my last question - too early in the morning!

Another question - how are you linking that paper to Pfizer?

Is it possible GlobalCo are working in partnership with Pfizer, but HEMO's agreement is with Globalco rather than Pfizer?

Also what has HEMO's CAR-T announcement got to do with someone else's CDX paper?

And when I say something similar maybe I should say 'looks similar to the layperson'.

You're assuming because the paper describes something similar to HEMO's CDX product that it must be HEMO's CDX product. Probably this assumption is false.

Clear implication that some tests have been carried out on monkeys, and that the next step was monkeys.

Re: monkeys you might want to watch the last 4-5 minutes of this presentation from November.

https://www.youtube.com/watch?v=WK9FrOukj-w

It's a TVR. Has to be issued at the end of any month where the number of shares in issues has changed. It changed in June due to the placing.

Real bid price is 6.05p so I think you're right.

https://lmgtfy.com/?q=what+is+a+closed+period

I reckon $7B (£12 a share) would do the trick - got my vote.

After SXX GC is going to be even more driven to make EML's potash mine a success and see it through to production.
It's going to be his magnum opus.

Very little significance.

LOL you can tell new@this is new to this.

That old PI chestnut myth that if a director buys there can't be any news for the next month.

Disproved time and time again.

Do you need me to explain director buying rules?

Best you sell then.

It's the finance director.
When the finance guy buys..

We'll see an erection all right, if you have the balls to hold.

Badly timed bs

My guess would be it's to do with the MM's having to balance their books at the end of the month or end of H1 maybe.